ESHO

Whole Body Hyperthermia: 
Randomized multicentric study of Ifosfamide, Carboplatin and Etoposide versus ICE combined with 41,8°C whole body hyperthermia in advanced non-small-cell lung cancer. 

Coordination: 

Dr. med. A. Bakhshandeh-Bath 
Lübeck 
I. Med. Klinik 
Universität Lübeck 
Tel: (0451) 500-2316 

Whole Body Hyperthermia: 
Open, randomized, muticentric phase III study of Carboplatin/Etoposide versus Car-boplatin/Etoposide combined with whole body hyperthermia in patients with advanced small-cell lung cancer ("extensive disease") 

Coordination: 

Prof. Dr. med. S. Hegewisch-Becker 
Abt. für Onkologie und Hämatologie 
Universitätsklinik Eppendorf 
Hamburg 
Tel: (040) 42803-3971 

Prof. Dr. med. Schlimok 
II. Med. Klinik 
Klinikum Augsburg 
Tel (0821) 400-2353